Track protection status across key markets to assess launch feasibility.
It is formulated by 8 pharmaceutical companies such as AZURITY, BIONPHARMA, ANNORA PHARMA and others. It is marketed under 3 brand names, including EPANED KIT, EPANED, ENALAPRIL MALEATE. Available in 5 different strengths, such as 1MG/ML, 2.5MG, 5MG and others, and administered through 3 routes including FOR SOLUTION;ORAL, SOLUTION;ORAL, TABLET;ORAL.
API availability: Loading API feasibility...
Licensing: 8 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
Strength | Route of Administration | Companies | Latest Approval Date |
---|
Patents approved by the FDA for the ingredient
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
---|---|---|---|---|---|
{"application_id":"56965","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED KIT","family_id":"49e4b50cfbf94af1ae8d","publication_number":"US8568747B1","cleaned_patent_number":"8568747","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-06","publication_date":"2013-10-29","legal_status":"Granted"} | US8568747B2 Formulation | 29 Oct, 2013 | Granted | 06 Nov, 2032 | |
{"application_id":"56960","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED KIT","family_id":"49e4b50cfbf94af1ae8d","publication_number":"US8778366B2","cleaned_patent_number":"8778366","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-06","publication_date":"2014-07-15","legal_status":"Granted"} | US8778366B2 | 15 Jul, 2014 | Granted | 06 Nov, 2032 | |
{"application_id":"56966","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED KIT","family_id":"49e4b50cfbf94af1ae8d","publication_number":"US9855214B2","cleaned_patent_number":"9855214","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-06","publication_date":"2018-01-02","legal_status":"Granted"} | US9855214B2 Formulation | 02 Jan, 2018 | Granted | 06 Nov, 2032 | |
{"application_id":"56967","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED KIT","family_id":"49e4b50cfbf94af1ae8d","publication_number":"US9968553B1","cleaned_patent_number":"9968553","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-06","publication_date":"2018-05-15","legal_status":"Granted"} | US9968553B2 | 15 May, 2018 | Granted | 06 Nov, 2032 | |
{"application_id":"76172","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US11040023B2","cleaned_patent_number":"11040023","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2021-06-22","legal_status":"Granted"} | US11040023B2 Formulation | 22 Jun, 2021 | Granted | 25 Mar, 2036 | |
{"application_id":"76173","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US11141405B2","cleaned_patent_number":"11141405","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2021-10-12","legal_status":"Granted"} | US11141405B2 Formulation | 12 Oct, 2021 | Granted | 25 Mar, 2036 | |
{"application_id":"76166","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US10039745B2","cleaned_patent_number":"10039745","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2018-08-07","legal_status":"Patented case"} | US10039745B2 Formulation | 07 Aug, 2018 | Patented case | 25 Mar, 2036 | |
{"application_id":"76165","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US9669008B1","cleaned_patent_number":"9669008","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2017-06-06","legal_status":"Granted"} | US9669008B2 Formulation | 06 Jun, 2017 | Granted | 25 Mar, 2036 | |
{"application_id":"76162","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US9808442B2","cleaned_patent_number":"9808442","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2017-11-07","legal_status":"Granted"} | US9808442B2 | 07 Nov, 2017 | Granted | 25 Mar, 2036 | |
{"application_id":"76174","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US11173141B2","cleaned_patent_number":"11173141","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2021-11-16","legal_status":"Granted"} | US11173141B2 Formulation | 16 Nov, 2021 | Granted | 25 Mar, 2036 | |
{"application_id":"76167","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US10154987B2","cleaned_patent_number":"10154987","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2018-12-18","legal_status":"Patented case"} | US10154987B2 | 18 Dec, 2018 | Patented case | 25 Mar, 2036 | |
{"application_id":"76168","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US10772868B2","cleaned_patent_number":"10772868","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2020-09-15","legal_status":"Patented case"} | US10772868B2 Formulation | 15 Sep, 2020 | Patented case | 25 Mar, 2036 | |
{"application_id":"76169","ingredient":"ENALAPRIL MALEATE","trade_name":"EPANED","family_id":"7c7bb16aad31409babd4","publication_number":"US10786482B2","cleaned_patent_number":"10786482","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-03-25","publication_date":"2020-09-29","legal_status":"Patented case"} | US10786482B2 Formulation | 29 Sep, 2020 | Patented case | 25 Mar, 2036 |
Latest clinical trials and research studies for this ingredient
NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
---|
Manufacturing Locations
Unlock access to all suppliers of Enalapril Maleate
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.